CD4 and infection: This could e.g. include antibodies blocking ESAT-6-mediated virulence or variations in local antigen concentration/positioning during infection, where effector CD4 T cells would need to recognize Mtb infected cells instead of bystander cells presenting soluble secreted antigens.